Ambagon Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Ambagon Therapeutics's estimated annual revenue is currently $5M per year.
- Ambagon Therapeutics's estimated revenue per employee is $77,500
- Ambagon Therapeutics's total funding is $103M.
Employee Data
- Ambagon Therapeutics has 65 Employees.
- Ambagon Therapeutics grew their employee count by 10% last year.
Ambagon Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder, CTO | Reveal Email/Phone |
2 | Co-Founder | Reveal Email/Phone |
3 | Co-Founder | Reveal Email/Phone |
4 | CEO | Reveal Email/Phone |
5 | VP Finance | Reveal Email/Phone |
6 | VP Chemistry | Reveal Email/Phone |
7 | VP & Head, Corporate Strategy & Business Development | Reveal Email/Phone |
8 | Executive Director | Reveal Email/Phone |
9 | Associate Director | Reveal Email/Phone |
10 | Chief Scientific Officer | Reveal Email/Phone |
Ambagon Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Ambagon Therapeutics?
Ambagon is discovering and developing small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins. Ambagon’s platform approach will open opportunities to address major unmet clinical needs beyond oncology.
keywords:N/A
$103M
Total Funding
65
Number of Employees
$5M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $9M | 65 | -23% | $4.6M |
#2 | $15M | 65 | -4% | $1.1B |
#3 | $75M | 65 | 18% | $2.2M |
#4 | $7.4M | 65 | -23% | $15.3M |
#5 | $7M | 65 | -19% | N/A |